This artice is free to access.
This is the protocol for a review and there is no abstract. The objectives are as follows: To systematically evaluate the beneficial and harmful effects of adding protease inhibitors to the current standard treatment of chronic hepatitis C with pegylated interferon and ribavirin.
Yaseen Alsabbagh, M. E., Davitkov, P., & Falck-Ytter, Y. (2013). Protease inhibitors in combination with pegylated interferon and ribavirin for adult patients with chronic hepatitis C virus. Cochrane Database of Systematic Reviews, 2013(6). https://doi.org/10.1002/14651858.CD010587